Literature DB >> 2431154

Location of antigenic epitopes on antibody molecules.

J Novotný, M Handschumacher, E Haber.   

Abstract

Using X-ray crystallographic co-ordinates of immunoglobulins, surface regions accessible to a large spherical probe, comparable in size to an antibody domain, were computed. Locations of these exposed regions were compared with those of experimentally determined antigenic sites, i.e. idiotypic, allotypic and isotypic serological markers. In all cases, an excellent agreement was found. The most prominent computed epitopes correspond to convex parts of antibody surface made by reverse turn segments of the polypeptide chain. The computed epitopes occur in homologous positions in all the immunoglobulin domains, and most of the beta-sheet surfaces on the domains are poorly antigenic. The CH2 domain (Fc fragment) has many more antigenic sites than the Fab fragments (antigen-binding fragments). Variable domain epitopes (idiotypes) involve both hypervariable and framework residues, and only about 25% of the hypervariable residues are strongly antigenic. The results indicate that, in a vertebrate body, each antibody molecule may be recognized, and its concentration regulated, by at least 40 complementary anti-immunoglobulin antibodies; therefore, a possibility of an "immune network" with much higher connectivity than is generally assumed should be seriously contemplated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431154     DOI: 10.1016/0022-2836(86)90502-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Immune network theory: a role for parallel distributed processing?

Authors:  F T Vertosick; R H Kelly
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

2.  Primary structure of the mouse protein encoded by the Igh1e allele of the n haplotype.

Authors:  S Klebert; B Zimmermann; M Vaesen; I Pardowitz; H D Kratzin; N Hilschmann
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

Authors:  A Y Liu; R R Robinson; K E Hellström; E D Murray; C P Chang; I Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains.

Authors:  G J Silverman; A H Lucas
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

5.  Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans.

Authors:  G J Silverman; R D Goldfien; P Chen; R A Mageed; R Jefferis; F Goñi; B Frangione; S Fong; D A Carson
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

6.  Molecular localization of human IgG anti-F(ab')2 reactivity with variable- and constant-region lambda light-chain epitopes.

Authors:  R C Williams; C C Malone; F Silvestris; A Solomon
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

7.  Do antibodies recognize amino acid side chains of protein antigens independently of the carbon backbone?

Authors:  V H Van Cleave; C W Naeve; D W Metzger
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

8.  Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements.

Authors:  Maha Z Ladjemi
Journal:  Front Oncol       Date:  2012-11-06       Impact factor: 6.244

9.  Characterizing complex polysera produced by antigen-specific immunization through the use of affinity-selected mimotopes.

Authors:  Galina Denisova; Dimitri Denisov; Carole Evelegh; Michaela Weissgram; Jochen Beck; Stephen Ronan Foley; Jonathan Lorne Bramson
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

Review 10.  The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant.

Authors:  Joseph R Moskal; Jeffrey S Burgdorf; Patric K Stanton; Roger A Kroes; John F Disterhoft; Ronald M Burch; M Amin Khan
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.